66 Biggest Movers From Yesterday

Gainers

• LMP Automotive Holdings, Inc. (NASDAQ:LMPX) shares jumped 75.5% to close at $13.92 on Tuesday.
• Venus Concept Inc. (NASDAQ:VERO) gained 74.8% to close at $5.21.
• Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) shares rose 27.2% to close at $6.92.
• Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) shares surged 26.8% to close at $7.96 on Tuesday.
• Iterum Therapeutics plc (NASDAQ:ITRM) shares climbed 21.9% to close at $4.85 on Tuesday.
• Gritstone Oncology, Inc. (NASDAQ:GRTS) gained 18% to close at $10.87.
• Equillium Inc (NASDAQ:EQ) rose 17% to close at $4.75 after the FDA granted fast track designation for Itolizumab for the treatment of Lupus Nephritis.
• Avid Bioservices Inc (NASDAQ:CDMO) gained 16.6% to close at $6.82 after the company reported better-than-expected Q2 EPS and sales results. First Analyst also upgraded the stock from Outperform to Strong Buy.
• Principia Biopharma Inc. (NASDAQ:PRNB) shares rose 16.5% to close at $48.90.
• KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) gained 16.4% to close at $6.96.
• Motus GI Holdings, Inc. (NASDAQ:MOTS) rose 16.3% to close at $2.35.
• Microbot Medical Inc. (NASDAQ:MBOT) surged 15.3% to close at $6.50.
• BlueLinx Holdings Inc. (NASDAQ:BXC) rose 15% to close at $11.79.
• EnLink Midstream, LLC (NYSE:ENLC) jumped 14.5% to close at $5.62.
• Osmotica Pharmaceuticals plc (NASDAQ:OSMT) rose 14.4% to close at $7.70.
• Evolent Health, Inc. (NYSE:EVH) jumped 14.2% to close at $8.99 after a report that Kentucky's contract review committee voted to approve Governor Bevin's Medicaid Contract decision which left out the company's passport.
• Lincoln Educational Services Corporation (NASDAQ:LINC) rose 14% to close at $2.3150.
• Forty Seven, Inc. (NASDAQ:FTSV) gained 13.9% to close at $34.65.
• Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) gained 13.6% to close at $12.92.
• Yunji Inc. (NASDAQ:YJ) rose 13.6% to close at $5.36.
• ObsEva SA (NASDAQ:OBSV) climbed 13% to close at $3.65 after RBC Capital maintained an Outperform rating on the company's stock and raised the price target from $18 to $19.
• Clovis Oncology, Inc. (NASDAQ:CLVS) rose 13% to close at $12.10 on continued momentum after Jim Cramer, on CNBC's "Mad Money," said he thinks the company is a good spec.
• Rubius Therapeutics, Inc. (NASDAQ:RUBY) surged 12.8% to close at $12.02.
• Proteostasis Therapeutics, Inc. (NASDAQ:PTI) rose 12.5% to close at $3.97.
• Electrameccanica Vehicles Corp. (NASDAQ:SOLO) gained 12.4% to close at $2.44.
• Aprea Therapeutics, Inc. (NASDAQ:APRE) shares rose 12.3% to close at $30.69.
• Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) gained 12.2% to close at $17.70 on continued upward momentum after the company announced URORA Phase 3 trial results of Voclosporin met primary endpoints and showed statistical significance in all pre-specified hierarchical secondary endpoints.
• bluebird bio, Inc. (NASDAQ:BLUE) gained 11.9% to close at $85.69 on updated results from its Phase 1 trial evaluating its CAR-T candidate bb21217.
• Fluent, Inc. (NASDAQ:FLNT) rose 11.9% to close at $2.36.
• Centogene N.V. (NASDAQ:CNTG) gained 11.7% to close at $9.05.
• Abeona Therapeutics Inc. (NASDAQ:ABEO) rose 11.6% to close at $3.28.
• Taitron Components Incorporated (NASDAQ:TAIT) surged 11% to close at $3.52.
• Synlogic, Inc. (NASDAQ:SYBX) shares gained 10.9% to close at $2.74.
• GTT Communications, Inc. (NYSE:GTT) surged 10.6% to close at $12.66.
• Puma Biotechnology, Inc. (NASDAQ:PBYI) gained 10.5% to close at $8.49.
• PG&E Corporation (NYSE:PCG) rose 10.2% to close at $12.32 on continued strength after the company on Monday announced a $13.5 billion settlement with CA wildfire victims.
• Epsilon Energy Ltd. (NASDAQ:EPSN) climbed 10.2% to close at $3.46.
• Arcadia Biosciences, Inc. (NASDAQ:RKDA) rose 10.2% to close at $5.86. Arcadia Biosciences, a developer of food ingredients and nutritional oils, with some pre-existing hemp assets and a partnership with Shane Victorino, a former MLB player and son of the mayor of Maui Mike Victorino, announced on Tuesday it's launching a new product line under the GoodHemp name.
• Dermira Inc (NASDAQ:DERM) gained 10.1% to close at $10.01 after the company received Fast Track destination for Lebrikizumab for the treatment of atopic dermatitis.
• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares rose 10% to close at $2.87.
• Stratus Properties Inc. (NASDAQ:STRS) gained 9.9% to close at $30.23. Ryman Hospitality Properties reported the purchase of Block 21 in Austin, Texas from Stratus Properties for $275 million.
• Magenta Therapeutics, Inc. (NASDAQ:MGTA) gained 9.5% to close at $14.00.
• Lightinthebox Holding Co Ltd-ADR (NYSE:LITB) gained 9.4% to close at $0.93 after the company reported Q3 EPS and sales are up from the same quarter last year.
• Ideal Power Inc. (NASDAQ:IPWR) surged 9% to close at $2.68.
• Wrap Technologies, Inc. (NASDAQ:WRTC) rose 8.7% to close at $6.40.
• Virgin Galactic Holdings Inc (NYSE:SPCE) gained 6.5% to close at $8.97.
• Sanofi (NYSE:SNY) rose 6.2% to close at $48.09. The company announced late Monday it will end its research in diabetes and cardiovascular and indicated it could sell its stake in Regeneron.
• Stitch Fix, Inc. (NASDAQ:SFIX) rose 4.8% to close at $26.23 after the company reported better-than-expected Q1 results. The company also reported active clients of 3.4 million, up 17% from the same quarter last year. The company announced that CFO Paul Yee will leave the company to pursue other career opportunities.
• Genworth Financial, Inc. (NYSE:GNW) rose 4.6% to close at $4.35 after Canadian regulators approved the sale of the company's stake in Genworth MI Canada to Brookfield Business Partners.

Check out these big penny stock gainers and losers

Losers

• Francesca's Holdings Corp (NASDAQ:FRAN) shares tumbled 37.3% to close at $12.44 on Tuesday after the company reported Q3 EPS results down from last year and worse-than-expected Q3 sales results.
• Conn's Inc (NASDAQ:CONN) shares fell 33.4% to close at $13.65 after the company reported worse-than-expected Q3 sales results. The company also issued Q4 total retail sales down 5%-9%.
• Chimerix, Inc. (NASDAQ:CMRX) dipped 20.2% to close at $2.02. Chimerix presented updated results from Phase 2 clinical trial of DSTAT in refractory myelodysplastic syndrome and acute myeloid leukemia at the American Society Of Hematology Annual Meeting.
• Construction Partners Inc (NASDAQ:ROAD) shares fell 18.8% to close at $16.73 after the company reported worse-than-expected Q4 EPS and sales results.
• Designer Brands Inc (NYSE:DBI) dropped 16.3% to close at $14.23 after the company reported worse-than-expected Q3 EPS results. The company also lowered its FY19 EPS guidance below analyst estimates.
• DarioHealth Corp. (NASDAQ:DRIO) dipped 14.3% to close at $7.11.
• Celyad SA (NASDAQ:CYAD) dropped 13.8% to close at $10.34. Celyad presented update on r/r AML and MDS program at the ASH 2019.
• Weidai Ltd. (NASDAQ:WEI) dipped 13.3% to close at $3.33.
• Beyond Air Inc (NASDAQ:XAIR) fell 12.3% to close at $3.57 after the company priced 2.325 million share common stock offering at $3.66 per share.
• Sangamo Therapeutics, Inc. (NASDAQ:SGMO) tumbled 12.2% to close at $9.06 on continued momentum after the company announced preliminary results from 3 patients in its Phase 1/2 study of ST-400.
• DermTech, Inc. (NASDAQ:DMTK) dropped 12% to close at $13.00.
• Cabaletta Bio, Inc. (NASDAQ:CABA) fell 9.9% to close at $8.21.
• Molecular Templates, Inc. (NASDAQ:MTEM) dropped 9.7% to close at $11.28.
• Casey's General Stores, Inc. (NASDAQ:CASY) shares declined 9.5% to close at $158.72 after the company reported worse-than-expected Q2 sales results.
• Canaan Inc. (NASDAQ:CAN) shares declined 9.4% to close at $6.57.
• Globus Maritime Ltd (NASDAQ:GLBS) fell 9.3% to close at $1.27 after the company reported sales of $4.95 million, up from $4.861 million in the same quarter last year.
• Livongo Health, Inc. (NASDAQ:LVGO) dropped 4.9% to close at $26.10 after the company announced a proposed public offering of 2.78 million shares by selling stockholders.